References

Hypoxia and hypoxia inducible factors: diverse roles in liver diseases

10.1002/hep.25497 · 2012 · External reference

Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies

2024 · External reference

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

10.1101/gad.12.2.149 · 1998 · External reference

Hypoxia signaling in human diseases and therapeutic targets

2019 · External reference

Basic biology of hypoxic responses mediated by the transcription factor HIFs and its implication for medicine

10.3390/biomedicines8020032 · 2020 · External reference

Biology of HIF-1alpha

10.1038/cdd.2008.12 · 2008 · External reference

HIF-1 and HIF-2 transcription factors—similar but not identical

10.1007/s10059-010-0067-2 · 2010 · External reference

HIF-α prolyl hydroxylase inhibitors and their implications for biomedicine: a comprehensive review

10.3390/biomedicines9050468 · 2021 · External reference

HIF-1alpha: a valid therapeutic target for tumor therapy

10.4143/crt.2004.36.6.343 · 2004 · External reference

HIF-1 at the crossroads of hypoxia, inflammation, and cancer

10.1002/ijc.29519 · 2016 · External reference

HIF-1α and VEGF immunophenotypes as potential biomarkers in atherosclerosis

10.31083/fbl27004 · 2025 · External reference

HIF-1α/BNIP3-mediated autophagy in liver injury

2023 · External reference

HIF-1A metabolic signature in liver organoids

10.1007/s10238-024-01521-x · 2024 · External reference

Chronic intermittent hypoxia accelerates liver fibrosis

10.1093/abbs/gmy169 · 2019 · External reference

Genetic loss of HIF-prolyl-hydroxylase 1 mitigates hepatic fibrosis

10.1016/j.ajpath.2024.10.018 · 2025 · External reference

Hypoxia-induced factor and liver fibrosis

10.7717/peerj.14299 · 2022 · External reference

Hepatocyte HIF-1 and intermittent hypoxia in NAFLD fibrosis

10.1165/rcmb.2020-0492oc · 2021 · External reference